Loss-of-function mutations of bcor are an independent marker of adverse outcomes in intensively treated patients with acute myeloid leukemia (2021) Eckardt JN, Stasik S, Kramer M, Röllig C, Krämer A, Scholl S, Hochhaus A, et al. Journal article Associations between genetically predicted circulating protein concentrations and endometrial cancer risk (2021) Zhu J, O’mara TA, Liu D, Setiawan VW, Glubb D, Spurdle AB, Fasching P, et al. Journal article Mr-guided hypofractionated radiotherapy: Current emerging data and promising perspectives for localized prostate cancer (2021) Cuccia F, Corradini S, Mazzola R, Spiazzi L, Rigo M, Bonù ML, Ruggieri R, et al. Journal article, Review article Lactonization of the oncometabolite d-2-hydroxyglutarate produces a novel endogenous metabolite (2021) Berger RS, Wachsmuth CJ, Waldhier MC, Renner-Sattler K, Thomas S, Chaturvedi A, Niller HH, et al. Journal article Excluding lung tissue from the ptv during internal mammary irradiation. A safe technique for oar-sparing? (2021) Borm KJ, Hofmann C, Duesberg M, Oechsner M, Dapper H, Devecka M, Combs SE Journal article Prognostic assessment in high-grade soft-tissue sarcoma patients: A comparison of semantic image analysis and radiomics (2021) Peeken JC, Neumann J, Asadpour R, Leonhardt Y, Moreira JR, Hippe DS, Klymenko O, et al. Journal article Implementation of double immune checkpoint blockade increases response rate to induction chemotherapy in head and neck cancer (2021) Semrau S, Gostian AO, Traxdorf M, Eckstein M, Rutzner S, von der Grün J, Illmer T, et al. Journal article Hypoxia and microvascular alterations are early predictors of IDH-mutated anaplastic glioma recurrence (2021) Stadlbauer A, Oberndorfer S, Heinz G, Zimmermann M, Kinfe TM, Dörfler A, Buchfelder M, et al. Journal article Feasibility and early clinical experience of online adaptive mr-guided radiotherapy of liver tumors (2021) Rogowski P, von Bestenbostel R, Walter F, Straub K, Nierer L, Kurz C, Landry G, et al. Journal article Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3) (2021) Apostolidis L, Dal Buono A, Merola E, Jann H, Jaeger D, Wiedenmann B, Winkler EC, Pavel ME Journal article